ArticleCancers2022

Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma.

W Quinn O'Neill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.